UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 295

Sortiert nach

Myositiden: Pathogenese und Therapie

Drug research, 2015-11, Vol.65 Suppl 1, p.S20

Wiendl, H

2015

Volltextzugriff (PDF)

The impact of lesion location on dysphagia incidence, pattern and complications in acute stroke. Part 1: dysphagia incidence, severity and aspiration

European journal of neurology, 2015-05, Vol.22 (5), p.832-838

2015

Volltextzugriff (PDF)

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

European journal of neurology, 2018-02, Vol.25 (2), p.215-237

2018

Volltextzugriff (PDF)

Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection

Current opinion in neurology, 2012-06, Vol.25 (3), p.322-333

2012

Volltextzugriff (PDF)

The impact of lesion location on dysphagia incidence, pattern and complications in acute stroke. Part 2: Oropharyngeal residue, swallow and cough response, and pneumonia

European journal of neurology, 2017-06, Vol.24 (6), p.867-874

2017

Volltextzugriff (PDF)

Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort

Neurology, 2012-05, Vol.78 (22), p.1736

2012

Volltextzugriff (PDF)

CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy

Neurology, 2012-02, Vol.78 (6), p.402

2012

Volltextzugriff (PDF)

Immune mechanisms of stroke

Current opinion in neurology, 2012-06, Vol.25 (3), p.334-340

2012

Volltextzugriff (PDF)

Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2002, Vol.16 (3), p.183-200

2002

Volltextzugriff (PDF)

Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children

Multiple sclerosis, 2011-03, Vol.17 (3), p.297-302

2011

Volltextzugriff (PDF)

Increased frequency of CD4⁺ CD25⁺ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients

Clinical and experimental immunology, 2007-03, Vol.147 (3), p.412-418

2007

Volltextzugriff (PDF)

Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis

European journal of paediatric neurology, 2019-11, Vol.23 (6), p.783-791

2019

Volltextzugriff (PDF)

Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control

Neurology, 2012-02, Vol.78 (7), p.458

2012

Volltextzugriff (PDF)

Immunophenotyping of cerebrospinal fluid cells in ischaemic stroke

European journal of neurology, 2019-06, Vol.26 (6), p.919-926

2019

Volltextzugriff (PDF)

Long-term effects of dalfampridine in patients with multiple sclerosis

Journal of the neurological sciences, 2014-02, Vol.337 (1), p.18-24

2014

Volltextzugriff (PDF)

Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy

Multiple sclerosis, 2013-08, Vol.19 (9), p.1209-1212

2013

Volltextzugriff (PDF)

Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

Journal of neuroimmune pharmacology, 2016-03, Vol.11 (1), p.1-8

2016

Volltextzugriff (PDF)

Frequency and risk factors associated with post-stroke dementia-an observational study on stroke patients without premorbid cognitive impairment

Nervenarzt, 2020-02, Vol.91 (2), p.131-140

2020

Volltextzugriff (PDF)

Concentric Sclerosis Baló: A rare Variant of Multiple Sclerosis

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2013-04, Vol.185 (4), p.301

2013

Volltextzugriff (PDF)

"Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients

Nervenarzt, 2010-06, Vol.81 (6), p.740-746

2010

Volltextzugriff (PDF)

Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells

Clinical and experimental immunology, 2008-02, Vol.151 (2), p.235-243

2008

Volltextzugriff (PDF)

Neuron-directed autoimmunity in the central nervous system: entities, mechanisms, diagnostic clues, and therapeutic options

Current opinion in neurology, 2012-06, Vol.25 (3), p.341-348

2012

Volltextzugriff (PDF)

Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study

Multiple sclerosis and related disorders, 2022-02, Vol.58, p.103404-103404, Article 103404

2022

Volltextzugriff (PDF)

Monomethylfumarate reduces in vitro migration of mononuclear cells

Neurological sciences, 2014-07, Vol.35 (7), p.1121-1125

2014

Volltextzugriff (PDF)

OP0056 12/15-lipoxygenase mediates GC-induced anti-inflammatory mechanisms in monocytes

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.72-72

2013

Volltextzugriff (PDF)

1 – 25 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(244)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myositiden: Pathogenese und Therapie

The impact of lesion location on dysphagia incidence, pattern and complications in acute stroke. Part 1: dysphagia incidence, severity and aspiration

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection

The impact of lesion location on dysphagia incidence, pattern and complications in acute stroke. Part 2: Oropharyngeal residue, swallow and cough response, and pneumonia

Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort

CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy

Immune mechanisms of stroke

Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials

Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children

Increased frequency of CD4⁺ CD25⁺ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients

Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis

Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control

Immunophenotyping of cerebrospinal fluid cells in ischaemic stroke

Long-term effects of dalfampridine in patients with multiple sclerosis

Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy

Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

Frequency and risk factors associated with post-stroke dementia-an observational study on stroke patients without premorbid cognitive impairment

Concentric Sclerosis Baló: A rare Variant of Multiple Sclerosis

"Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients

Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells

Neuron-directed autoimmunity in the central nervous system: entities, mechanisms, diagnostic clues, and therapeutic options

Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study

Monomethylfumarate reduces in vitro migration of mononuclear cells

OP0056 12/15-lipoxygenase mediates GC-induced anti-inflammatory mechanisms in monocytes

Suchergebnisse filtern